IR@PKUHSC  > 北京大学第一临床医学院  > 临床药理研究所
学科主题临床医学
Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers
Xiao, Y.; Lu, Y.; Kang, Z.; Hou, F.; Wang, S.; Li, T.; Liu, Y.; Xia, Y.
关键词Antofloxacin Hydrochloride Multiple Dose Pharmacokinetics Tolerability Healthy Chinese Male Volunteers Serum Urine
刊名INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
2008-04-01
46期:4页:172-179
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy
研究领域[WOS]Pharmacology & Pharmacy
英文摘要

Objective: To evaluate the tolerability and pharmacokinetics characteristics of antofloxacin hydrochloride, a fluoroquinolone developed in China, after multiple oral doses in healthy male Chinese volunteers. Methods: 13 subjects took 300 mg of antofloxacin hydrochloride once daily for 7 days. Safety was evaluated on Days 0, 2, 4 and 8. Blood and urine samples for pharmacokinetics analysis were taken at designated time points. HPLC was used to assay the serum and urine concentration of antofloxacin. Results: A total of 12 subjects completed the trial and 1 volunteer was dropped because of a skin rash 2 h after the drug was administered. 1 volunteer had a prolonged prothrombin time (PT), another had a serum alanine aminotransferase (ALT) elevation and a third had increases in aspartate aminotransferase (AST) and gamma-glutamyltransferase (gamma-GT). No other complaints were reported during the trial. The steady state serum concentration on a daily 300 mg oral dose was obtained at 96 h. The pharmacokinetics parameters at steady state were: t(max) 1.19 +/- 0.59 h, C-max 4.49 +/- 0.81 mg/1, C-min 1.35 +/- 0.33 mg/1, AUC(ss) 74.74 +/- 12.58 mg/1 x h, C-av 3.11 +/- 0.52 mg/1, t(1/2 beta) 20.75 +/- 2.93 h, PTF 102.13 +/- 23.92%. The urinary elimination of antofloxacin over 120 h after the last dose was approximately 62%. C-max in steady state was 50% higher compared to data for Day 1 after a single dose administration. Conclusions: The results indicated that 300 mg antofloxacin hydrochloride once daily oral administration is safe, but can lead to high drug concentrations. This should be evaluated further.

语种英语
WOS记录号WOS:000255069200003
引用统计
被引频次:12[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/55847
专题北京大学第一临床医学院_临床药理研究所
作者单位Peking Univ, First Hosp, Inst Clin Pharmacol, Beijing 100871, Peoples R China
推荐引用方式
GB/T 7714
Xiao, Y.,Lu, Y.,Kang, Z.,et al. Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers[J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS,2008,46(4):172-179.
APA Xiao, Y..,Lu, Y..,Kang, Z..,Hou, F..,Wang, S..,...&Xia, Y..(2008).Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS,46(4),172-179.
MLA Xiao, Y.,et al."Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers".INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 46.4(2008):172-179.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xiao, Y.]的文章
[Lu, Y.]的文章
[Kang, Z.]的文章
百度学术
百度学术中相似的文章
[Xiao, Y.]的文章
[Lu, Y.]的文章
[Kang, Z.]的文章
必应学术
必应学术中相似的文章
[Xiao, Y.]的文章
[Lu, Y.]的文章
[Kang, Z.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。